STATE STREET CORP - Tenax Therapeutics ownership

Tenax Therapeutics's ticker is and the CUSIP is 88032L506. A total of 17 filers reported holding Tenax Therapeutics in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of Tenax Therapeutics
ValueSharesWeighting
Q3 2023$28,042
-1.7%
95,1220.0%0.00%
Q2 2023$28,537
-35.5%
95,1220.0%0.00%
Q1 2023$44,23295,1220.00%
Other shareholders
Tenax Therapeutics shareholders Q3 2023
NameSharesValueWeighting ↓
Virtu Financial LLC 36,799$110.00%
TUCKER ASSET MANAGEMENT LLC 2$10.00%
Corient Private Wealth LLC 191,460$56,4450.00%
Avantax Planning Partners, Inc. 10,002$2,9910.00%
Allworth Financial LP 1$10.00%
Lido Advisors, LLC 10,000$2,9900.00%
WELLS FARGO & COMPANY/MN 160$480.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 118,978$35,0740.00%
STATE STREET CORP 95,122$28,0420.00%
View complete list of Tenax Therapeutics shareholders